Co-Author
This page shows the publications co-authored by Nader Rifai and Julie Buring.
Connection Strength
1.114
-
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005 Jul 20; 294(3):326-33.
Score: 0.080
-
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003 Jan 28; 107(3):391-7.
Score: 0.068
-
Is C-reactive protein specific for vascular disease in women? Ann Intern Med. 2002 Apr 02; 136(7):529-33.
Score: 0.064
-
Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001 Jan 30; 103(4):491-5.
Score: 0.059
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000 Mar 23; 342(12):836-43.
Score: 0.056
-
Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Cancer Res. 2016 12 15; 76(24):7160-7167.
Score: 0.044
-
Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):855-61.
Score: 0.034
-
A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst. 2013 Jan 16; 105(2):95-103.
Score: 0.034
-
Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood. 2012 Dec 13; 120(25):4929-37.
Score: 0.033
-
Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):82-91.
Score: 0.031
-
Lipoprotein(a) and risk of type 2 diabetes. Clin Chem. 2010 Aug; 56(8):1252-60.
Score: 0.028
-
Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men. Int J Mol Epidemiol Genet. 2010; 1(3):167-74.
Score: 0.028
-
Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009 Sep 17; 361(12):1152-63.
Score: 0.027
-
Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem. 2009 May; 55(5):888-94.
Score: 0.026
-
Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 2009 Feb 24; 119(7):931-9.
Score: 0.026
-
Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts. Diabetes Care. 2009 Feb; 32(2):329-34.
Score: 0.025
-
Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation. 2008 Sep 02; 118(10):993-1001.
Score: 0.025
-
Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events. J Am Coll Cardiol. 2008 Jul 08; 52(2):124-31.
Score: 0.025
-
Interleukin-18 and the risk of future cardiovascular disease among initially healthy women. Atherosclerosis. 2009 Jan; 202(1):282-8.
Score: 0.024
-
Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study. Clin Chem. 2008 Jan; 54(1):139-46.
Score: 0.024
-
Intercellular adhesion molecule 1 (ICAM1) Lys56Met and Gly241Arg gene variants, plasma-soluble ICAM1 concentrations, and risk of incident cardiovascular events in 23,014 initially healthy white women. Stroke. 2007 Dec; 38(12):3152-7.
Score: 0.023
-
Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia. 2007 Oct; 50(10):2076-84.
Score: 0.023
-
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med. 2007 Aug; 120(8):720-7.
Score: 0.023
-
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007 Jul 18; 298(3):309-16.
Score: 0.023
-
Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem. 2007 May; 53(5):845-51.
Score: 0.022
-
High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol. 2007 Mar; 125(3):300-5.
Score: 0.022
-
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007 Feb 14; 297(6):611-9.
Score: 0.022
-
Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA. 2006 Sep 20; 296(11):1363-70.
Score: 0.022
-
Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Circulation. 2006 Aug 01; 114(5):381-7.
Score: 0.022
-
A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women. Cancer Res. 2006 Mar 01; 66(5):2869-75.
Score: 0.021
-
C-reactive protein and the risk of developing hypertension. JAMA. 2003 Dec 10; 290(22):2945-51.
Score: 0.018
-
Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation. 2003 Dec 16; 108(24):2993-9.
Score: 0.018
-
Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women. Am J Med. 2003 Apr 15; 114(6):438-44.
Score: 0.017
-
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002 Nov 14; 347(20):1557-65.
Score: 0.017
-
Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002 Oct 01; 22(10):1668-73.
Score: 0.017
-
Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol. 2002 May 01; 89(9):1117-9.
Score: 0.016
-
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001 Jul 18; 286(3):327-34.
Score: 0.015
-
Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 1999 Aug 17; 100(7):713-6.
Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.